[Cost-benefit-risk analysis of estrogen treatment in the climacteric].
D001943:Breast Neoplasms / Q000139:chemically induced; D002979:Climacteric / Q000187:drug effects*; D003362:Cost-Benefit Analysis; D045166:Estradiol Congeners / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D012306:Risk; D014594:Uterine Neoplasms / Q000139:chemically induced
D045166:Estradiol Congeners
Kosten-Nutzen-Risiko-Analyse der Ostrogenbehandlung im Klimakterium.